|
|
|
Dr Warren S Raye
Research fellow
BSc Murdoch University
BSc(Hons) Murdoch University
PhD Murdoch University
Telephone: +61 3 9903 9083
Fax: +61 3 9903 9638
Email: warren.raye@pharm.monash.edu.au
-
Differentiation of embryonic and neural stem cells
-
Functional characterisation of stem cells
-
Molecular approaches to therapeutic drug development
-
Pathogenicity and characterisation of novel circoviruses
-
Molecular approaches to viral disease detection and control
Representative publications
- Jazayeri J, Upadhyay A, Sharma G, Raye WS, Kivivuori S, Carroll GJ. Role of a leukaemia inhibitory factor (LIF) antagonist in LIF and Oncostatin M (OSM) induced MMP-1, MMP-3 and TIMP-1 expression by primary articular chondrocytes. Submitted to Cytokine — 2009 accepted for publication.
- Klopcic B, Appelbee A, Raye WS, Lloyd F, Jooste JC, Forrest CH, et.al. Indomethacin and Retinoic Acid Modify Mouse Intestinal Inflammation and Fibrosis: A Role for SPARC. Dig Dis Sci. 2008; 53(6):1553–1563.
- Jazayeri JA, De Weerd N, Raye WS, Kivivuori S, Zabihi E, Carroll GJ. In vitro evaluation of leukaemia inhibitory factor receptor antagonists as candidate therapeutics for inflammatory arthritis. J Interferon Cytokine Res. 2007; 27(4):281–9.
- Raye WS, Tochon-Danguy N, Pouton CW, Haynes JM. Heterogeneous population of dopaminergic neurons derived from mouse embryonic stem cells: preliminary phenotyping based on receptor expression and function. Eur J Neurosci. 2007; 25(7):1961–1970.
- Jazayeri JA, De Weerd N, Raye WS, Velkov T, Santos L, Taylor D, et.al. Generation of mutant leukaemia inhibitory factor (LIF)-IgG heavy chain fusion proteins as bivalent antagonists of LIF. J Immunol Methods. 2007; 323(1):1–10.
- Muhling J, Raye WS, Buddle JR, Wilcox GE. Genetic characterisation of Australian strains of porcine circovirus types 1 and 2. Aust Vet J. 2006; 84(12):421–5.
- Raye WS, Muhling J, Warfe L, Buddle JR, Palmer C, Wilcox GE. The detection of porcine circovirus in the Australian pig herd. Aust Vet J. 2005; 83(5):300–4.
- Lawrance I, Lloyd F, Puolakkainen PA, Sage EH, Raye WS. Sparc protects against chronic murine inflammation-induced intestinal fibrosis. Gastroenterology. 2005; 128:A207–A207.
- Lawrance IC, Lloyd F, Raye WS. A role for SPARC in the extracellular matrix changes in IBD. Gastroenterology. 2004; 126:A568–A568.
|